🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wendy A. Keitel

Baylor College of Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
8.4Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A framework for human microbiome research

Nature(2012)10.1038/nature11209
Top 2%
8.4DataRank
Top 2%2766 citations

Barbara A. Methé, William Nelson, Mihai Pop, Heather H. Creasy, Michelle Giglio +236 more

Papers

Driven by 14 papers — median percentile 98. Top paper: “A framework for human microbiome research”.

A framework for human microbiome research

Nature(2012)10.1038/nature11209
Top 2%
8.4DataRank
Top 2%2766 citations

Barbara A. Methé, William Nelson, Mihai Pop, Heather H. Creasy, Michelle Giglio +236 more

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100679
N/A
5.1DataRank · unranked
167 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul Paul Chourdhury +64 more

Structure, function and diversity of the healthy human microbiome

Nature(2012)10.1038/nature11234
N/A
1.4DataRank · unranked
10088 citations

Curtis Huttenhower, Dirk Gevers, Rob Knight, Sahar Abubucker, Jonathan H. Badger +235 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4
N/A
1.3DataRank · unranked
56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z
N/A
1.1DataRank · unranked
33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00735-6
N/A
0.996DataRank · unranked
25 citations

Nadine Rouphael, Ruxana T. Sadikot, Maria C. Rodriguez‐Barradas, Micah T. McClain, Dana M Wilkins +32 more

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

Clinical Infectious Diseases(2024)10.1093/cid/ciae173
N/A
0.384DataRank · unranked
11 citations

Robert L. Atmar, Emmanuel B. Walter, Sharon E. Frey, Jeffery L. Meier, Amy C Sherman +23 more

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad276
N/A
0.312DataRank · unranked
7 citations

İnci Yıldırım, Sharon E. Frey, Patricia Winokur, Lisa A. Jackson, David I. Bernstein +26 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465
N/A
0.251DataRank · unranked
3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Challenges and lessons learned from the rapid operationalization of a prospective cohort to study the natural history and neurodevelopmental outcomes of postnatal Zika virus infection among infants and children in rural Guatemala

PLoS neglected tropical diseases(2022)10.1371/journal.pntd.0010480
N/A
0DataRank · unranked
5 citations

Daniel Olson, Amy K. Connery, Diva M. Calvimontes, Guillermo A. Bolaños, Molly M. Lamb +20 more

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf571
N/A
0DataRank · unranked
1 citations

Theresa Hegmann, Hana M. El Sahly, Evan J. Anderson, DMID 15-0038 Study Group, Nancy B. Wagner +14 more

Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants

Vaccine(2020)10.1016/j.vaccine.2020.05.059
N/A
0DataRank · unranked
28 citations

Shital M. Patel, Lisa A. Jackson, Geeta K. Swamy, Kathryn M. Edwards, Sharon E. Frey +4 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323
N/A
0DataRank · unranked
3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Postnatal Zika and Dengue Infection and their Effects on Neurodevelopment Among Children Living in Rural Guatemala

The Pediatric Infectious Disease Journal(2024)10.1097/inf.0000000000004646
N/A
0DataRank · unranked
3 citations

Amy Connery, Daniel Olson, Molly M. Lamb, Alejandra Paniagua-Ávila, Evan J. Anderson +21 more